ExodusPoint Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-80,346
| Closed | -$3.17M | – | 1888 |
|
|
2025
Q1 | $3.17M | Buy |
+80,346
| New | +$3.17M | 0.03% | 505 |
|
|
2024
Q4 | – | Sell |
-278,302
| Closed | -$6.51M | – | 1929 |
|
|
2024
Q3 | $6.51M | Sell |
278,302
-822,996
| -75% | -$19.2M | 0.04% | 287 |
|
|
2024
Q2 | $19.6M | Buy |
1,101,298
+539,706
| +96% | +$9.6M | 0.13% | 111 |
|
|
2024
Q1 | $8.54M | Buy |
561,592
+507,362
| +936% | +$7.72M | 0.07% | 197 |
|
|
2023
Q4 | $926K | Sell |
54,230
-140,937
| -72% | -$2.41M | 0.01% | 781 |
|
|
2023
Q3 | $1.63M | Buy |
195,167
+39,519
| +25% | +$330K | 0.02% | 712 |
|
|
2023
Q2 | $3.87M | Buy |
155,648
+132,083
| +561% | +$3.28M | 0.03% | 478 |
|
|
2023
Q1 | $354K | Buy |
+23,565
| New | +$354K | ﹤0.01% | 1332 |
|
|
2022
Q4 | – | Sell |
-136,021
| Closed | -$805K | – | 2061 |
|
|
2022
Q3 | $805K | Buy |
136,021
+83,168
| +157% | +$492K | 0.01% | 1162 |
|
|
2022
Q2 | $225K | Buy |
52,853
+4,223
| +9% | +$18K | ﹤0.01% | 1577 |
|
|
2022
Q1 | $462K | Buy |
+48,630
| New | +$462K | 0.01% | 1517 |
|
|
2019
Q4 | – | Sell |
-22,877
| Closed | -$128K | – | 1818 |
|
|
2019
Q3 | $128K | Buy |
22,877
+81
| +0.4% | +$453 | ﹤0.01% | 1178 |
|
|
2019
Q2 | $197K | Buy |
+22,796
| New | +$197K | 0.01% | 907 |
|